[ANAB]
Mid
Mid
2026-10-21 04:52:28
AnaptysBio quickly drops amid hearing on GSK/Tesaro contract breach
Mid
2026-10-20 02:28:36
AnaptysBio gains as GSK granted FDA label expansion for Jemperli
Row
2026-10-13 12:45:01
Anaptysbio director Renton Hollings sells $249,371 of shares
Mid
2026-10-10 17:25:50
AnaptysBio earnings beat by $5.58, revenue topped estimates
Mid
2026-09-23 02:11:25
AnaptysBio earnings analysis: questions answered and next catalysts
1 / 2